Suppr超能文献

孤立性 IgG4 相关性巨大冠状动脉瘤复发:病例报告并复习文献,重点关注治疗策略和并发症。

Solitary recurrence of IgG4-related giant coronary aneurysm: Case report and review of the literature focusing on treatment strategies and complications.

机构信息

Department of Rheumatology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.

Department of Cardiovascular Surgery, National Hospital Organization Kanazawa Medical Center, Kanazawa, Japan.

出版信息

Mod Rheumatol Case Rep. 2023 Dec 29;8(1):182-194. doi: 10.1093/mrcr/rxad065.

Abstract

Coronary periarteritis is a dangerous manifestation of IgG4-related disease, because it forms coronary artery aneurysms, which may cause sudden cardiac death. We report the case of a 78-year-old woman with IgG4-related coronary periarteritis and a coronary aneurysm, which showed progressive enlargement despite maintenance therapy for Type 1 autoimmune pancreatitis. This case was unique, in that coronary periarteritis was the only active lesion that recurred. Low-dose glucocorticoids suppressed the progression of periarterial lesions but led to rapid thinning of the aneurysmal wall and an increase in the size of mural thrombi, which pose a risk of myocardial infarction. Our systematic literature review including 98 cases of 86 articles was performed to examine its treatment strategies and complications. Among the cases in which the effect of immunosuppressive therapy could be followed radiologically, 33 of 37 (89.1%) cases showed improvement in wall thickening/periarterial soft tissue, while 6 of 13 (46.2%) showed worsening increase in the outer diameter of the coronary aneurysms. We propose a draft treatment algorithm and suggest that immunosuppressive therapy for IgG4-related coronary periarteritis with coronary aneurysms should be conducted only after the therapeutic benefit has been determined to outweigh the risks. Because coronary periarteritis can occur without other organ involvement, as in our case, all cases of IgG4-related disease require careful monitoring of coronary artery lesions.

摘要

冠状动脉周围炎是 IgG4 相关疾病的一种危险表现,因为它会形成冠状动脉瘤,可能导致心源性猝死。我们报告了一例 78 岁女性 IgG4 相关冠状动脉周围炎和冠状动脉瘤的病例,尽管维持治疗 1 型自身免疫性胰腺炎,但该冠状动脉瘤仍进行性增大。该病例较为独特,因为冠状动脉周围炎是唯一复发的活动性病变。小剂量糖皮质激素抑制了动脉周围病变的进展,但导致动脉瘤壁变薄和血栓形成增加,增加了心肌梗死的风险。我们进行了一项系统的文献回顾,包括 86 篇文章中的 98 例病例,以研究其治疗策略和并发症。在可通过影像学随访免疫抑制治疗效果的病例中,37 例中的 33 例(89.1%)显示壁增厚/动脉周围软组织改善,而 13 例中的 6 例(46.2%)显示冠状动脉瘤外径恶化增加。我们提出了一个治疗方案草案,并建议只有在确定免疫抑制治疗 IgG4 相关冠状动脉周围炎合并冠状动脉瘤的治疗益处大于风险后,才应进行治疗。因为冠状动脉周围炎可在无其他器官受累的情况下发生,如我们的病例所示,所有 IgG4 相关疾病的病例均需要仔细监测冠状动脉病变。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验